Conditions: Gram-Positive Bacterial Infections
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 60
Healthy volunteers: no

Brief summary:
The purpose of this study is to determine whether telavancin (TD-6424, ARBELIC) can be safety administered to patients with bloodstream infections and whether telavancin is effective in treating these infections.

Detailed description:

Arms:
arm 1: None arm 2: Vancomycin 1 Gram/12 hours or nafcillin, oxacillin, or cloxacillin 2 Gram/6 hours (IV) intravenously

Interventions: intervention 1: Telavancin intervention 2: Vancomycin, nafcillin, oxacillin, or cloxacillin
Intervention descriptions: intervention 1: Telavancin 10mg/kg/day IV every 24 hrs for up to 14 days intervention 2: Vancomycin 1 Gram every 12 hr IV (intravenously) OR nafcillin, oxacillin, or cloxacillin 2 Grams every 6 hr IV (intravenously) for up to 14 days.

Protocol document: